Whatever You Do Get Ana Elsia On

Lab Reagents

Assay Elisa Laboratories manufactures the whatever you do get ana elsia on reagents distributed by Genprice. The Whatever You Do Get Ana Elsia On reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Assay elisa. Other Whatever products are available in stock. Specificity: Whatever Category: You Group: Do Get

Do Get information

Rat Osteonectin (ON) ELISA Kit

RDR-ON-Ra-48Tests 48 Tests
EUR 534

Rat Osteonectin (ON) ELISA Kit

RDR-ON-Ra-96Tests 96 Tests
EUR 742

Human Osteonectin (ON) ELISA Kit

RD-ON-Hu-48Tests 48 Tests
EUR 478

Human Osteonectin (ON) ELISA Kit

RD-ON-Hu-96Tests 96 Tests
EUR 662

Mouse Osteonectin (ON) ELISA Kit

RD-ON-Mu-48Tests 48 Tests
EUR 489

Mouse Osteonectin (ON) ELISA Kit

RD-ON-Mu-96Tests 96 Tests
EUR 677

Rat Osteonectin (ON) ELISA Kit

RD-ON-Ra-48Tests 48 Tests
EUR 511

Rat Osteonectin (ON) ELISA Kit

RD-ON-Ra-96Tests 96 Tests
EUR 709

GDF15 Cardiotoxicity ELSIA Kit

GDF15E1 1 Kit
EUR 307

DO-264

HY-114157 50mg
EUR 1083

Rabbit lipoprotein Alpha ELSIA Kit

ELA-E0842Rb 96 Tests
EUR 928

ANA-12

2878-10
EUR 196

ANA-12

2878-50
EUR 631

ANA 12

B5712-100 100 mg
EUR 699
Description: ANA 12 is a potent and selective antagonist of TrkB with IC50 values of 45.6 nM and 41.1 ?M for the high and low affinity sites, respectively [1].

ANA 12

B5712-25 25 mg
EUR 293
Description: ANA 12 is a potent and selective antagonist of TrkB with IC50 values of 45.6 nM and 41.1 ?M for the high and low affinity sites, respectively [1].

ANA 12

B5712-5 5 mg
EUR 131
Description: ANA 12 is a potent and selective antagonist of TrkB with IC50 values of 45.6 nM and 41.1 ?M for the high and low affinity sites, respectively [1].

ANA 12

B5712-5.1 10 mM (in 1mL DMSO)
EUR 154
Description: ANA 12 is a potent and selective antagonist of TrkB with IC50 values of 45.6 nM and 41.1 ?M for the high and low affinity sites, respectively [1].